Jinyu Bio-technology Co., Ltd.

SHSE:600201 Stok Raporu

Piyasa değeri: CN¥7.4b

Jinyu Bio-technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Jinyu Bio-technology's earnings have been declining at an average annual rate of -6.2%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 3.1% per year. Jinyu Bio-technology's return on equity is 2.9%, and it has net margins of 12.2%.

Anahtar bilgiler

-6.2%

Kazanç büyüme oranı

-5.7%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.3%
Gelir büyüme oranı3.1%
Özkaynak getirisi2.9%
Net Marj12.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Sep 04
The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02
Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jun 16
Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Apr 30
Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Mar 21
There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Feb 28
Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Gelir ve Gider Dağılımı

Jinyu Bio-technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SHSE:600201 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 241,350165468122
30 Jun 241,525272479137
31 Mar 241,582283510149
31 Dec 231,598284518143
30 Sep 231,639289477155
30 Jun 231,572240461145
31 Mar 231,551236436133
31 Dec 221,529211423134
30 Sep 221,546174461158
30 Jun 221,578229462161
31 Mar 221,599252487164
31 Dec 211,776382503166
30 Sep 211,813529456142
30 Jun 211,798482454138
31 Mar 211,735467418137
31 Dec 201,582406399131
30 Sep 201,387268399111
30 Jun 201,24023435796
31 Mar 201,15921335590
31 Dec 191,12722134587
30 Sep 191,31232237791
30 Jun 191,646565389107
31 Mar 191,673617395111
31 Dec 181,897754413107
30 Sep 182,008869502106
30 Jun 181,909842476114
31 Mar 181,99790046987
31 Dec 171,90187044872
30 Sep 171,80984239642
30 Jun 171,6517484130
31 Mar 171,6357194240
31 Dec 161,5176454150
30 Sep 161,3935613770
30 Jun 161,3095183630
31 Mar 161,2525053560
31 Dec 151,2474803560
30 Sep 151,2104993280
30 Jun 151,1164363300
31 Mar 151,0634332970
31 Dec 141,0634043110
30 Sep 149213462780
30 Jun 148743082500
31 Mar 148492772310
31 Dec 136712512200

Kaliteli Kazançlar: 600201 has high quality earnings.

Büyüyen Kar Marjı: 600201's current net profit margins (12.2%) are lower than last year (17.6%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 600201's earnings have declined by 6.2% per year over the past 5 years.

Büyüme Hızlandırma: 600201's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 600201 had negative earnings growth (-42.9%) over the past year, making it difficult to compare to the Biotechs industry average (0.08%).


Özkaynak Getirisi

Yüksek ROE: 600201's Return on Equity (2.9%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin